R. Taylor Ripley, M.D. Thoracic Surgeon
@RTaylorRipley
Followers
2K
Following
390
Media
158
Statuses
581
Meyer-DeBakey Chair in Investigative Surgery; Director, Mesothelioma, Thoracic Research, Clinical Trials @BCM_Surgery; Editor, Seminars JTCVS
Houston, TX
Joined May 2016
Targeting two proteins in the BCL-2 pathway was specific to the mitochondria @bcmhouston @BCMFromtheLabs @BCM_Surgery @BCMCancerCenter #mesothelioma
1
1
6
The mitochondria with highly damaged by targeting two proteins in the mitochondria @bcmhouston @BCMFromtheLabs @BCM_Surgery @BCMCancerCenter #mesothelioma
0
0
1
Actively enrolling in NEMO for patients with surgically resectable pleural #mesothelioma @BCM_Surgery @bcmhouston @BCMCancerCenter
@BCMFromtheLabs 713-798–LUNG (6376) or lungsched@bcm.edu
0
0
2
Congrats to Dr. Yuan Xu and our team @BCM_Surgery @bcmhouston @BCMFromtheLabs @BCM_Thoracic who showed that co-targeting the mitochondria can induce lethal dysfunction in pleural #mesothelioma. @curemeso
https://t.co/Ypj32pms1f
aacrjournals.org
Abstract. Diffuse mesothelioma is a rare but highly aggressive and treatment-resistant neoplasm with low survival rates. Effective therapeutic strategies are limited, and resistance to treatment is a...
0
0
4
Man survives with titanium heart for 100 days – a world first @BCM_Surgery @TXMedCenter @Texas_Heart
nature.com
Nature - The device, to be tested in more people, could be used as a temporary measure for those waiting for a donor organ.
1
10
51
Congrats, Dr Davis! Well deserved. Looking forward to seeing years of outstanding work.
Thanks for the warm welcome! @UMMC @UMmedschool
0
0
12
Actively enrolling in NEMO for patients with #mesothelioma in which patients receive three cycles of immunotherapy or chemoimmunotherapy followed by surgery followed by one year of immunotherapy @BCM_Surgery @bcmhouston @BCMCancerCenter @BCMFromtheLabs 713-798–LUNG (6376).
0
3
20
Our peer-reviewed, pre-print response to MARS2 for #surgery #mesothelioma online @AATSJournals @AATSHQ. Thank you and congratulations to all the authors who wrote this article. Going to MARS May Shorten Our Patient’s Survival - The Journal of Thoracic and Cardiovascular Surgery
1
6
28
Thank you, Shanda. We have and outstanding team @BCM_Surgery @BCMFromtheLabs @bcmhouston @BCMCancerCenter focused on translating our scientific work to patient care. @ShandaBlackmon @DrRosengart. #mesothelioma #esophagealcancer #lcmc
@BCM_Surgery @BCMLungInst busy Friday as Dr. Taylor Ripley creates an inclusive and inspiring environment in his weekly lab meeting. Biobanking, novel therapy, basic science, innovation- all being discussed.
1
1
17
Agree. Dysphasia is as sensitive as EUS. Lower stages uncommon and risks of nodal positivity is high.
@biniamkidaneMD @DrShawnGroth @okusanyamd @DouglasAdlerMD @LFerri123 @Daniela_Molena @ShandaBlackmon @RTaylorRipley @BCM_Thoracic Actually, probably do not need EUS with dysphagia. Paper from @RTaylorRipley @MSK_Thoracic
https://t.co/oRRget2ftf
0
0
12
Attention @TXMedCenter physicians, APPs, RNs, and trainees -cutting edge critical care from leaders; practical advice to take back to your unit @BCM_Surgery @BCMDeptMedicine @BCMAnesthesia @Texas_Heart
@SXC71 and I invite you to join us #ACC2024 A fantastic blend of local and national expert speakers under a unique presentation format. Here are the ones coming from other states/countries. https://t.co/S869HWi7y0
0
4
11
Alterations in human gene #TRPC5 cause #obesity and #postpartumDepression. See our interview with @DrYongXu1, @Farooqi_Lab about this work in @CellCellPress @bcmhouston @Cambridge_Uni
blogs.bcm.edu
TRPC5 acts on a brain region that regulates multiple innate behaviors including feeding, anxiety, socialization and maternal care.
0
3
7
In Ripley-Xu Lab, the Mitochondria Continue to Knock-Out Mesothelioma, Lung and Esophageal Cancer @BCM_Surgery @bcmhouston @BCMCancerCenter @BCMFromtheLabs @BCM_Thoracic Thank you @ScottHolmesCMI for the image!
0
2
14
Monica Vilchis exemplifies excellence @bcmhouston @BCM_Surgery @BCMFromtheLabs @BCM_Thoracic @DrRosengart @ShandaBlackmon @DrShawnGroth. She is instrumental in the multiple clinical trials in our division of thoracic surgery!
#StaffSpotlight Monica Vilchis is a CR Supervisor @BCM_Thoracic working on the TSOG 101 ctDNA, TSOG 102 GGO, & TSOG 104 Mesothelioma studies. Her emphasis on timely & effective communication makes her a consummate team player and an asset to the TSOG team. @BCM_Surgery
1
5
21
Enrollment is underway for NEMO with 3 Cycles Durva/Treme w/wo Cis/Peme followed by Surgery, followed by 1-Yr Durvalumab. @BCM_Surgery @bcmhouston @BCMCancerCenter @BCM_Thoracic for patients with #Mesothelioma. @AstraZeneca @AATSHQ. 713-798-6376 or lungsched@bcm.edu
Actively enrolling in NEMO for patients with #mesothelioma in which patients receive three cycles of immunotherapy or chemoimmunotherapy followed by surgery followed by one year of immunotherapy @BCM_Surgery @bcmhouston @BCMCancerCenter @BCMFromtheLabs 713-798–LUNG (6376).
0
3
12
New in Seminars in #Thoracic and #Cardiovascular Surgery: Surgical Outcomes After Reconstruction of the Aortomitral Curtain. See the recommendations based on the researcher's conclusions: https://t.co/zAGocN6neT
@KeckMedicineUSC @KECKSchool_USC
0
3
13
Actively enrolling in NEMO for patients with #mesothelioma in which patients receive three cycles of immunotherapy or chemoimmunotherapy followed by surgery followed by one year of immunotherapy @BCM_Surgery @bcmhouston @BCMCancerCenter @BCMFromtheLabs 713-798–LUNG (6376).
0
1
8
Mapping Clinical Trial Activation @BCM_Surgery @bcmhouston @BCMFromtheLabs. The Office of Surgical Research is tirelessly working to streamline the processes.
0
1
13
Ripley-Xu lab at @BCM_Surgery @bcmhouston @BCMFromtheLabs growing rapidly to study mechanisms underlying therapeutic resistance! Clean and ready to go!
1
3
23
Now enrolling in NEMO for patients with resectable pleural #mesothelioma @bcmhouston @BCM_Surgery @BCMCancerCenter @BCM_Thoracic @BCMFromtheLabs Study on Durvalumab, Tremelimumab and chemotherapy for Mesothelioma | BCM
0
1
6